Connect with us

Hi, what are you looking for?

BestMarketInsiders.comBestMarketInsiders.com

Editor's Pick

Elon Musk sports black eye at farewell presser in Oval Office: ‘Horsing around with little X’

Elon Musk showed up to the Oval Office on Friday to bid farewell to his official role in the Trump administration, but it wasn’t just the mark he made with DOGE that raised eyebrows.

It was the black one under his right eye. 

Social media lit up during the livestreamed event as eagle-eyed viewers noticed what appeared to be a fresh bruise under Musk’s eye, prompting speculation about everything from a gym mishap to a political dust-up. 

The assembled press couldn’t resist asking the obvious: ‘What happened to your eye?’

‘Well, I wasn’t anywhere near France,’ Musk quipped, poking fun at headlines regarding French President Emmanuel Macron, who was caught on camera being shoved by his wife last week. ‘I didn’t know the first lady of France isn’t a lieutenant.’

Then came the real story.

‘No, I just was horsing around with little X,’ Musk said, referring to his five-year-old son, X Æ A-Xii. ‘And I said, ‘Go ahead, punch me in the face.’ And he did. Turns out even a 5-year-old punching you in the face… actually does this.’

President Donald Trump jumped in immediately. ‘That was X that did that?’

‘Yeah,’ Musk replied.

‘X could do it, if you knew X,’ Trump said with a grin.

The whole exchange, captured during Musk’s Oval Office farewell event, quickly became the moment of the day, a lighthearted pause in a sendoff marking the end of Musk’s 130-day stint as head of the Department of Government Efficiency (DOGE).

Musk didn’t let the black eye distract from his message.

‘This is not the end of DOGE,’ he told reporters. ‘Only the beginning.’

According to a May 26 update on DOGE’s official site, the department racked up over $175 billion in savings during Musk’s tenure, mostly through asset sales, canceled contracts, and cracking down on fraud. That translates to an estimated $1,087 saved per taxpayer.

The White House did not immediately respond to Fox News Digital’s request for comment.

This post appeared first on FOX NEWS

You May Also Like

World News

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) crashed more than 15% this morning on disappointing data from Phase 3 trials of its experimental drug itepekimab. Itepekimab...

World News

Argentina made its return to global debt markets this week, selling its first significant bond in seven years. The $1 billion offering, priced in...

Business

While U.S. President Donald Trump’s tariffs play out in U.S. courts, another one of his proposed laws could weaponize the American tax system. Investment...

Stock

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) crashed more than 15% this morning on disappointing data from Phase 3 trials of its experimental drug itepekimab. Itepekimab...